Login / Signup

Safety of biologics in severe asthmatic patients with SARS-CoV-2 infection: A prospective study.

Sara MantiAlessandro GiallongoGiulia PecoraGiuseppe Fabio ParisiMaria PapaleEnza MulèDonatella AloisioNovella RotoloSalvatore Leonardi
Published in: Pediatric pulmonology (2023)
We showed that the scheduled dose of the biologic therapy can be administered safely on time in patients with SARS-CoV-2 infection, as the treatment did not result in adverse events or outcomes.
Keyphrases
  • respiratory syndrome coronavirus
  • rheumatoid arthritis
  • early onset
  • lung function
  • stem cells
  • chronic obstructive pulmonary disease
  • cystic fibrosis
  • coronavirus disease
  • insulin resistance